![](/img/cover-not-exists.png)
35 GENOTYPIC CHARACTERISATION OF FILIBUVIR (PF-00868554) RESISTANCE IN PATIENTS RECEIVING FOUR WEEKS CO-ADMINISTRATION OF FILIBUVIR WITH PEGIFN/RBV (12 WEEK ANALYSIS)
J. Mori, J.L. Hammond, S. Srinivasan, S. Jagannatha, E. van der RystVolume:
52
Year:
2010
Language:
english
DOI:
10.1016/s0168-8278(10)60037-2
File:
PDF, 47 KB
english, 2010